News | Enterprise Imaging | May 26, 2022

The attestation boosts ScImage’s security posture

ScImage, Inc., a leading provider of cloud-centric enterprise imaging, PACS, and image exchange solutions for the healthcare industry, announced today it has successfully completed its SOC 2 Type 1 report, in accordance with attestation standards established by the American Institute of Certified Public Accountants (AICPA).

May 26, 2022 — ScImage, Inc., a leading provider of cloud-centric enterprise imaging, PACS, and image exchange solutions for the healthcare industry, announced today it has successfully completed its SOC 2 Type 1 report, in accordance with attestation standards established by the American Institute of Certified Public Accountants (AICPA). The achievements underscore ScImage’s commitment to strong internal controls.

SOC 2 is an internationally recognized compliance standard for service organizations, developed by the AICPA (American Institute of CPAs), which specifies how companies should manage and maintain customer data.

Many companies put software into a hosted environment, such as MS Azure, Amazon Web Services, and Google, relying solely on the host’s security strategy, said ScImage’s President and CEO, Sai Raya, PhD.

“SOC 2 Type 1 report for PICOM365 Cloud Enterprise Imaging Services system allows ScImage to demonstrate that we are successfully merging the wealth of security and monitoring features built into the MS Azure platform with our own specific controls and information security wisdom acquired over decades of experience. ScImage is fully committed to the principles of security, confidentiality, and availability,” he said.

Dr. Raya noted that ScImage has been seeing an increase in the number of security documentation requests as the healthcare industry transitions from on-premise to Cloud-based workflow.

ScImage is not new to compliance initiatives. The company’s PicomEnterprise software suite is an FDA 510k approved medical device, and ScImage was granted a Risk Management Framework (RMF)-based Authority to Operate (ATO) authorized by the Defense Health Agency (DHA) in 2017.

“The formal SOC 2 report path, including independent 3PAO audits, is an attestation that ScImage will continue to grow our established service commitments, system requirements, and corporate policies to not only meet, but exceed our valued customers’ and partners’ expectations,” he concluded.

The effort was completed by the professional and independent third-party cybersecurity and compliance audit firm, 360 Advanced, Inc.

For more information: https://scimage.com/


Related Content

News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Enterprise Imaging

May 16, 2024 — AGFA HealthCare announced that St. Vincent’s Private Hospital in Dublin, Ireland, has chosen to implement ...

Time May 16, 2024
arrow
News | Artificial Intelligence

May 16, 2024 — deepc, the globally recognized digital medicine pioneer and market leader behind the leading AI operating ...

Time May 16, 2024
arrow
Sponsored Content | Case Study | Enterprise Imaging

Having the most efficient clinical workflows with enhanced diagnostic capabilities is a major goal for clinicians and ...

Time May 16, 2024
arrow
News | Enterprise Imaging

May 15, 2024 — etherFAX announced the expansion of its partnership with Hyland, a leading global provider of intelligent ...

Time May 15, 2024
arrow
News | Cybersecurity

May 13, 2024 — In the wake of the cybersecurity breach targeting the prominent healthcare system Ascension, a new study ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | ARRS

May 8, 2024 — Compared to males, women in radiology are at a consistently higher risk of not matching into diagnostic ...

Time May 08, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
Subscribe Now